No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Axitinib
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / secondary
-
Disease Management
-
Everolimus
-
Humans
-
Imidazoles / therapeutic use
-
Indazoles / therapeutic use
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / pathology
-
Practice Guidelines as Topic
-
Randomized Controlled Trials as Topic
-
Sirolimus / analogs & derivatives
-
Sirolimus / therapeutic use
-
Treatment Failure
Substances
-
Antineoplastic Agents
-
Imidazoles
-
Indazoles
-
Everolimus
-
Axitinib
-
Sirolimus